Journal
AMERICAN JOURNAL OF HEMATOLOGY
Volume 90, Issue 11, Pages 1071-1076Publisher
WILEY
DOI: 10.1002/ajh.24177
Keywords
-
Categories
Ask authors/readers for more resources
Polo-like kinases (Plks) plays a central role in the normal cell cycle and their upregulation has been shown to play a role in the pathogenesis of multiple human cancers. Preclinical work demonstrates that targeting Plk has a significant impact on the treatment of both solid and hematologic malignancies in vitro and in vivo. We review here the basic science and clinical work to date with the Plks as well as future directions with this novel class of mitotic inhibitors. Am. J. Hematol. 90:1071-1076, 2015. (c) 2015 Wiley Periodicals, Inc.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available